News LEO launches chronic hand eczema drug in its first market Germany has become the debut market for LEO Pharma's Anzupgo, the first topical treatment specifically approved for chronic hand eczema (CHE).
News LEO closes on first approval for chronic hand eczema drug Danish dermatology specialist LEO Pharma could be just weeks away from EU approval for delgocitinib, a treatment for chronic hand eczema (CHE) considered to be its top pipeline prospect.
News EC's von der Leyen loses bid to stop disclosure of Pfizer te... Ursula von der Leyen has lost a lawsuit attempting to force her to disclose text messages with Pfizer's CEO on COVID-19 vaccine procurement.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.